Task: Answer the multiple-choice question.
Question: Which drug exhibits a -1.105\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] Cc1ccc(NC(=O)c2ccc(CNc3c(N4CCOCC4)c(=O)c3=O)cc2)cc1
[b] CCCCN(CC)C(=O)Cc1ccc(Br)cc1
[c] Cc1nn(CC(=O)NCCCN2CCCCC2)c(=O)c2cccn12
Answer: a. Cc1ccc(NC(=O)c2ccc(CNc3c(N4CCOCC4)c(=O)c3=O)cc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(NC(=O)c2ccc(CNc3c(N4CCOCC4)c(=O)c3=O)cc2)cc1
Cc1ccc(NC(=O)c2ccc(CNc3c(N4CCOCC4)c(=O)c3=O)cc2)cc1
N-(4-methylphenyl)-4-[[(2-morpholin-4-yl-3,4-dioxocyclobuten-1-yl)amino]methyl]benzamide